PensionDanmark Pensionsforsikringsaktieselskab Boosts Position in Danaher Corporation $DHR

PensionDanmark Pensionsforsikringsaktieselskab boosted its holdings in Danaher Corporation (NYSE:DHR) by 13.2% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 134,442 shares of the conglomerate’s stock after purchasing an additional 15,725 shares during the quarter. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in Danaher were worth $25,609,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. JPL Wealth Management LLC purchased a new position in shares of Danaher in the 3rd quarter valued at $25,000. Main Street Group LTD purchased a new stake in Danaher in the first quarter valued at $25,000. WFA of San Diego LLC acquired a new position in Danaher in the second quarter valued at $26,000. Elevated Capital Advisors LLC purchased a new position in shares of Danaher during the fourth quarter worth about $26,000. Finally, Hilton Head Capital Partners LLC purchased a new position in shares of Danaher during the fourth quarter worth about $27,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on DHR shares. Robert W. Baird dropped their price target on Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a research note on Friday, April 17th. Guggenheim cut their target price on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Argus reduced their price target on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Friday, April 24th. The Goldman Sachs Group lowered their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Monday, April 13th. Finally, HSBC dropped their price objective on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Danaher Stock Performance

DHR opened at $200.01 on Friday. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The stock has a market cap of $140.61 billion, a P/E ratio of 35.53, a P/E/G ratio of 2.49 and a beta of 0.78. The stock’s 50 day simple moving average is $190.23 and its 200 day simple moving average is $194.24. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.77 EPS. As a group, equities analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.